Skip to content

Company

Altimmune

United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Altimmune?

Held by 42 covered funds. Sorted by Altimmune’s share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
BBCVirtus LifeSci Biotech Clinical Trials0.7%
QQQSInvesco NASDAQ Future Gen 2000.3%
SBIOALPS Medical Breakthroughs0.3%
XBIState Street(R) SPDR(R) S&P(R) Biotech0.2%
IWCiShares Micro-Cap0.1%
GCAVXGMO U.S. Small Cap Value Fund0.1%
FSEGFidelity Enhanced Small Cap Growth0.1%
GMCQXGMO U.S. Equity Fund0.0%
PWSPacer WealthShield0.0%
IBBiShares Biotechnology0.0%
IWNiShares Russell 2000 Value0.0%
FESMFidelity Enhanced Small Cap Core0.0%
IBBQInvesco Nasdaq Biotechnology0.0%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.0%
VTWGVanguard Russell 2000 Growth Index Fund0.0%
NSIDXSmall Cap Index Fund0.0%
IWMiShares Russell 20000.0%
RSSLGlobal X Russell 20000.0%
RESMColumbia Research Enhanced Small Cap0.0%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
VTWOVanguard Russell 2000 Index Fund0.0%
ITWOProShares Russell 2000 High Income0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
VHTVanguard Health Care Index Fund0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
VXFVanguard Extended Market Index Fund0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
DFASDimensional U.S. Small Cap0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTIVanguard Total Stock Market Index Fund0.0%
DCORDimensional US Core Equity 10.0%
VTHRVanguard Russell 3000 Index Fund0.0%
AVSUAvantis Responsible U.S. Equity0.0%
IWViShares Russell 30000.0%
DFUSDimensional U.S. Equity Market0.0%
DFACDimensional U.S. Core Equity 20.0%
DFAUDimensional US Core Equity Market0.0%
SSBIXState Street Balanced Index Fund0.0%
AVSCAvantis U.S. Small Cap Equity0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Altimmune news

No recent stories about Altimmune.